Protection against Aß-mediated rapid disruption of synaptic plasticity and memory by memantine.
Neurobiol Aging
; 32(4): 614-23, 2011 Apr.
Article
em En
| MEDLINE
| ID: mdl-19446369
ABSTRACT
Soluble amyloid-ß protein (Aß) may cause cognitive impairment in Alzheimer's disease in the absence of significant neurodegeneration. Here, the ability of the NMDA receptor (NMDAR) antagonist memantine to prevent synthetic Aß-mediated rapid functional deficits in learned behavior and synaptic plasticity was assessed in the rat. In vitro, pretreatment with a clinically relevant, NMDAR blocking concentration of memantine partially inhibited the induction of long-term potentiation (LTP) in the dentate gyrus and prevented further inhibition caused by exposure to Aß(1-42). Whereas systemic injection with memantine alone inhibited LTP in the CA1 area in vivo, a subthreshold dose partially abrogated the inhibition of LTP by intracerebroventricular soluble Aß(1-42). Similarly, systemic treatment with memantine alone impaired performance of an operant learning task and a subthreshold dose prevented the Aß(1-42)-mediated increase in perseveration errors. The acute protection afforded by memantine, albeit in a narrow dose range, against the rapid disruptive effects of soluble Aß(1-42) on synaptic plasticity and learned behavior strongly implicate NMDAR-dependent reversible dysfunction of synaptic mechanisms in Aß-mediated cognitive impairment.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Sinapses
/
Memantina
/
Peptídeos beta-Amiloides
/
Potenciação de Longa Duração
/
Fármacos Neuroprotetores
/
Hipocampo
/
Aprendizagem
Limite:
Animals
Idioma:
En
Ano de publicação:
2011
Tipo de documento:
Article